Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 14.6K sh |
| Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | D'Amico AndrewDirector | Option exercise · 10b5-1 plan | M | $20K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Grant or award · 10b5-1 plan | A | — 300.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $94K 2,678 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 2,678 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $25K 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 5,893 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Inukonda RaviCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | — 1,017 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Grant or award · 10b5-1 plan | A | — 44.7K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 62.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $2,446 321 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 56 | McNally Kevin JosephTrustee | Open-market purchase | BUY | $5,135 634 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 56 | Versaci Vincent WTrustee | Open-market purchase | BUY | $11K 1,336 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 52 | Versaci Vincent WTrustee | Open-market purchase | BUY | $3,016 371 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 50 | Liu Teyin MDirector | Open-market purchase | BUY | $3.91M 11.6K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 48 | Neufeld Leah RCHIEF PEOPLE OFFICER | Open-market purchase | BUY | $11K 2,626 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 48 | Weber Clifford JohnTrustee | Open-market purchase | BUY | $8,160 1,000 sh | Jan 15, 2026 traded Jan 15, 2026 |
| 47 | Gayle OswaldChief Financial Officer | Open-market purchase | BUY | $1,162 700 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 46 | McNally Kevin JosephTrustee | Open-market purchase | BUY | $6,240 1,000 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 44 | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Open-market sale | SELL | $2.87M 100.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 44 | Eager William WPresident, S&P Global Mobility | Open-market purchase | BUY | $5,954 11 sh | Jan 15, 2026 traded Sep 10, 2025 |
| 43 | Gayle OswaldChief Financial Officer | Open-market purchase | BUY | $507 300 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 43 | Stokes CameronSee Remarks | Open-market purchase | BUY | $4,244 450 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 42 | Liu Teyin MDirector | Open-market purchase | BUY | $1.27M 3,780 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 42 | Liu Teyin MDirector | Open-market purchase | BUY | $2.64M 7,820 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 42 | Weber Clifford JohnTrustee | Open-market purchase | BUY | $6,000 1,000 sh | Jan 15, 2026 traded Jan 15, 2026 |
| 40 | Saintil MerlineDirector | Open-market sale · 10b5-1 plan | SELL | $8.31M 96.0K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 38 | Donohoe Bryan PatrickChief Executive Officer | Open-market sale | SELL | $107K 21.8K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 36 | Tkach CameronExecutive Vice President, COO | Open-market sale | SELL | $3,664 745 sh | Jan 15, 2026 traded Jan 2, 2025 |
| 35 | Eager William WPresident, S&P Global Mobility | Open-market purchase | BUY | $5,964 12 sh | Jan 15, 2026 traded Dec 10, 2025 |